Sign up Australia
Realm Therapeutics plc (LON:RLM)

Realm Therapeutics plc (LON:RLM)


Share Price
8.25 p
Change
-0.25 (-2.94 %)
Market Cap
£9.62 m
Proactive Investors - Run By Investors For Investors

Realm Therapeutics plc

Realm Therapeutics is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children.   The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations.  The Company believes their formulations have novel immunomodulatory...

EPIC: RLM
Market: LSE:RLM
52-week High/Low: 49.00p / 8.00p
Sector: Pharma & Biotech
Market Cap: 9.62M
Website: www.realmtx.com

Realm Therapeutics plc

www.realmtx.com

Interactive graph

col 3
col 4
col 5
col 6

Realm Therapeutics plc Timeline

RNS
October 10 2018
RNS
October 09 2018
RNS
October 06 2018
RNS
October 05 2018

Market Reports Including RLM

VIEW ALL

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use